Abdominal obesity leads to reduction of hepatic and insulin sensitivity (39), as visceral adipose tissue is highly resistant to insulin and susceptible to lipolysis, thus producing excess free fatty acids than adipose tissue in other sites (40). The gene discussed is INS; the disease is Abdominal obesity.